DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Intravenous (IV) Iron Drugs Market: Industry Analysis & Outlook (2017-2021)" report to their offering.
"Global I.V. Iron Drugs Market" provides a comprehensive study of iron product market and I.V. iron market globally. It also provides detailed information for key regional markets of I.V iron industry. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry, Galenica Group, AMAG Pharmaceuticals and Allergan are being profiled. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.
The global market of I.V. iron drugs is increasing at a very fast pace owing to rising incidences of chronic kidney disease (CKD), iron deficiency diseases related to gynecology, nephrology, gastroenterology, and oncology. Moreover, the global intravenous iron drugs market is estimated to grow in the coming years due to the rising demand for non-dextran I.V. iron drugs.
The key factors driving the growth of I.V. iron drugs market are growing ageing population, growing urbanization, increase in number of dialysis cases, rising healthcare expenditure and increasing life expectancy rate. Some of the noteworthy trends and developments of this industry are paradigm shift from oral iron drugs to intravenous iron drugs and introduction of first generation drugs InFeD and Dexeferrum. However, the expansion of the market is hindered by potential risks of I.V. iron.
Key Topics Covered:
1. I.V. Iron Market - An Overview
2. Global Iron Product Market Analysis
3. Global I.V. Iron Drugs Market Analysis
4. Regional Market Analysis
5. Market Dynamics
6. Competitive Landscape
7. Company Profiles
- AMAG Pharmaceuticals
- Allergan plc.
- Galenica Group
For more information about this report visit http://www.researchandmarkets.com/research/9qfdtc/global